Gap junction disorders of myelinating cells

Reviews in the Neurosciences

Volumn 21, Issue 5, 2010, Pages 397-419

  Kleopa, Kleopas A ^a   Orthmann Murphy, Jennifer ^b   Sargiannidou, Irene ^a  

^a CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 29; CONNEXIN 32; CONNEXIN 47; GAP JUNCTION PROTEIN; MYELIN; SHAKER POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ASTROCYTE; CELL MEMBRANE TRANSPORT; CELL TYPE; DEMYELINATION; GAP JUNCTION; GENE FUNCTION; GENE MUTATION; GENETIC DISORDER; GRAY MATTER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKODYSTROPHY; MYELIN SHEATH; MYELINATION; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PERIPHERAL NERVE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SCHWANN CELL; SPASTIC PARAPLEGIA; WHITE MATTER;

EID: 78651331996     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2010.21.5.397     Document Type: Review

References (174)

1. Kumar NM, Gilula NB. The gap junction communication channel. Cell. 1996;84:381-389.
2. Maeda S, Nakagawa S, Suga M, Yamashita E, Tsukihara T. Structure of the connexin 26 gap junction channel at 3.5 A resolution. Nature. 2009;458:597-602.
3. Bruzzone R, White TW, Paul DL. Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem. 1996;238:1-27. (Pubitemid 26164180)
4. White TW, Paul DL. Genetic diseases and gene knockouts reveal diverse connexin functions. Annu Rev Physiol. 1999;61:283-310.
5. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu Rev Biochem. 1996;65:475-502.
6. White TW, Bruzzone R. Multiple connexin proteins in single intercellular channels: connexin compatibility and functional consequences. J Bioenerg Biomembranes. 1996;28:339-350. (Pubitemid 26269689)
7. Dahl E, Manthey D, Chen Y, Schwarz HJ, Chang YS, Lalley PA, Nicholson BJ, Willecke K. Molecular cloning and functional expression of mouse connexin-30, a gap junction gene highly expressed in adult brain and skin. J Biol Chem. 1996;271:17903-17910. (Pubitemid 26250770)
8. Bukauskas FF, Elfgang C, Willecke K, Weingart R. Heterotypic gap junction channels (connexin26 - connexin32) violate the paradigm of unitary conductance. Pflugers Arch - Eur J Physiol. 1995; 429:870-872.
9. Schubert AL, Schubert W, Spray DC, Lisanti MP. Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry. 2002;41:5754-5764.
10. Akiyama M, Ishida N, Ogawa T, Yogo K, Takeya T. Molecular cloning and functional analysis of a novel Cx43 partner protein CIP150. Biochem Biophys Res Commun. 2005;335:1264-1271.
11. Sotkis A, Wang XG, Yasumura T, Peracchia LL, Persechini A, Rash JE, Peracchia C. Calmodulin colocalizes with connexins and plays a direct role in gap junction channel gating. Cell Commun Adhes 2001;8:277-281.
12. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Güldenagel M, Deutsch U, Söhl G. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem. 2002;383:725-737.
13. Unger VM, Kumar NM, Gilula NB, Yeager M. Three-dimensional structure of a recombinant gap junction membrane channel. Science. 1999;283: 1176-1180.
14. Yeager M, Nicholson BJ. Structure of gap junction intercellular channels. Curr Opin Struct Biol. 1996; 6:183-192.
15. Musil LS, Goodenough DA. Multisubunit assembly of an integral plasma membrane channel protein, gap junction connexin43, occures after exit from the ER. Cell. 1993;74:1075-1077.
16. Kumar NM, Friend DS, Gilula NB. Synthesis and assembly of human bl gap junctions in BHK cells by DNA transfection with the human b1 cDNA. J Cell Sci. 1995;108:3725-3734.
17. Das Sarma J, Wang FS, Koval M. Targeted gap junction protein constructs reveal connexin-specific differences in oligomerization. J Biol Chem. 2002; 277:20911-20918. (Pubitemid 34967400)
18. Maza J, Das Sarma J, Koval M. Defining a minimal motif required to prevent connexin oligomerization in the endoplasmic reticulum. J Biol Chem. 2005; 280:21115-21121. (Pubitemid 40805671)
19. Huang Y, Sirkowski EE, Stickney JT, Scherer SS. Prenylation-defective human connexin32 mutants are normally localized and function equivalently to wild-type connexin32 in myelinating Schwann cells. J Neurosci. 2005;25:7111-7120.
20. Silvius JR. Mechanisms of Ras protein targeting in mammalian cells. J Membr Biol. 2002;190:83-92.
21. Wright LP, Philips MR. Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J Lipid Res. 2006;47:883-891.
22. Söhl G, Gillen C, Bosse F, Gleichmann M, Muller HW, Willecke K. A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur J Cell Biol. 1996;69:267-275.
23. Scherer SS, Deschênes SM, Xu Y-T, Grinspan JB, Fischbeck KH, Paul DL. Connexin32 is a myelin- related protein in the PNS and CNS. J Neurosci. 1995;15:8281-8294.
24. Chandross KJ, Kessler JA, Cohen RI, Simburger E, Spray DC, Bieri P, Dermietzel R. Altered connexin expression after peripheral nerve injury. Mol Cell Neurosci. 1996;7:501-518.
25. Ressot C, Bruzzone R. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease. Brain Res Rev. 2000;32:192-202.
26. Sandri C, Van Buren JM, Akert K. Membrane morphology of the vertebrate nervous system. Prog Brain Res. 1982;46:201-265.
27. Tetzlaff W. Tight junction contact events and temporary gap junctions in the sciatic nerve fibres of the chicken during Wallerian degeneration and subsequent regeneration. J Neurocytol. 1982;11: 839-858.
28. Schnapp BJ, Mugnaini E. Membrane architecture of myelinated fibers as seen by freeze-fracture. In: Waxman SG, ed. Physiology and Pathobiology of Axons. New York: Raven Press; 1978:83-123.
29. Meier C, Dermietzel R, Davidson KG, Yasumura T, Rash JE. Connexin32-containing gap junctions in Schwann cells at the internodal zone of partial myelin compaction and in Schmidt-Lanterman incisures. J Neurosci. 2004;24:3186-3198.
30. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 1993;262: 2039-2042. (Pubitemid 24041884)
31. Balice-Gordon RJ, Bone LJ, Scherer SS. Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol. 1998;142:1095-1104.
32. Altevogt BM, Kleopa KA, Postma FR, Scherer SS, Paul DL. Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci. 2002;22:6458-6470.
33. Söhl G, Theis M, Hallas G, Brambach S, Dahl E, Kidder G, Willecke K. A new alternatively spliced transcript of the mouse connexin32 gene is expressed in embryonic stem cells, oocytes, and liver. Exp Cell Res. 2001;266:177-186. (Pubitemid 32989054)
34. Anzini P,Neuberg DH, Schachner M, Nelles E, Willecke K, Zielasek J, Toyka KV, Suter U, Martini R. Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. Neuroscience 1997;17:4545-4561.
35. Scherer SS, Xu Y-T, Nelles E, Fischbeck K, Willecke K, Bone LJ. Connexin32-null mice develop a demyelinating peripheral neuropathy. Glia 1998;24:8-20. (Pubitemid 28370208)
36. Jeng LJ, Balice-Gordon RJ, Messing A, Fischbeck KH, Scherer SS. The effects of a dominant connexin32 mutant in myelinating Schwann cells. Mol Cell Neurosci. 2006;32:283-298. (Pubitemid 44026520)
37. Sargiannidou I, Vavlitou N, Aristodemou S, Hadjisavvas A, Kyriacou K, Scherer SS, Kleopa KA.Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects. J Neurosci. 2009;29: 4748-4761.
38. Ahn M, Lee J, Gustafsson A, Enriquez A, Lancaster E, Sul JY, Haydon PG, Paul DL, Huang Y, Abrams CK, Scherer SS. Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct. J Neurosci Res. 2008;86:992-1006. (Pubitemid 351441297)
39. Sargiannidou I, Ahn M, Enriquez AD, Peinado A, Reynolds R, Abrams C, Scherer SS, Kleopa KA. Human oligodendrocytes express Cx31.3: function and interactions with Cx32 mutants. Neurobiol Dis. 2008;30:221-233.
40. Konishi T. Voltage-gated potassium currents in myelinating Schwann cells in the mouse. J Physiol. 1990;431:123-139.
41. Chiu SY. Functions and distribution of voltage- gated sodium and potassium channels in mammalian Schwann cells. Glia. 1991;4:541-558.
42. Stolinski C, Breathnach AS, Thomas PK, Gabriel G, King RMH. Distribution of particle aggregates in the internodal axolemma and adaxonal Schwann cell membrane of rodent peripheral nerve. J Neurol Sci. 1985;67:213-222.
43. Nagy JI, Rash JE. Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Rev. 2000;32:29-44.
44. Rash JE, Yasumura T, Dudek FE, Nagy JI. Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. J Neurosci. 2001;21: 1983-2000.
45. Kleopa KA, Orthmann JL, Enriquez A, Paul DL, Scherer SS. Unique distribution of gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes. Glia. 2004;47:346-357.
46. Altevogt BM, Paul DL. Four classes of intercellular channels between glial cells in the CNS. J Neurosci. 2004;24:4313-4323.
47. Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL. Connexins are critical for normal myelination in the CNS. J Neurosci. 2003; 23:5963-5973.
48. Odermatt B, Wellershaus K, Wallraff A, Seifert G, Degen J, Euwens C, Fuss B, Büssow H, Schilling K, Steinhäuser C, Willecke K.Connexin 47 (Cx47)- deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocyte expression of Cx47 and display vacuolized myelin in the CNS. J Neurosci. 2003;23: 4549-4559.
49. Nagy JI, Ionescu AV, Lynn BD, Rash JE. Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice. Glia. 2003;44:205-218.
50. Kamasawa N, Sik A, Morita M, Yasumura T, Davidson KG, Nagy JI, Rash JE.Connexin-47 and connexin-32 in gap junctions of oligo-dendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning. Neuroscience 2005;136:65-86.
51. Orthmann-Murphy JL, Freidin M, Fischer E, Scherer SS, Abrams CK. Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J Neurosci 2007;27:13949-13957. (Pubitemid 351377852)
52. Nagy JI, Ionescu AV, Lynn BD, Rash JE. Connexin29 and connexin32 at oligodendrocyte and astrocyte gap junctions and in myelin of the mouse central nervous system. J Comp Neurol. 2003; 22:356-370.
53. Kettenmann H, Orkand RK, Schachner M. Coupling among identified cells in mammalian nervous system cultures. J Neurosci. 1983;3:506-16. (Pubitemid 13132716)
54. Ransom BR, Kettenmann H. Electrical coupling, without dye coupling, between mammalina astrocytes and oligodendrocytes in cell culture. Glia. 1990;3:258-266.
55. Giaume C, Fromaget C, El Aoumari A, Cordier J, Glowinski J, Gros D. Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron. 1991; 6:133-143.
56. Robinson SR, Hampson ECGM, Munro MN, Vaney DI. Unidirectional coupling of gap junctions between neuroglia. Science. 1993;262:1072-1074.
57. Rouach N, Glowinski J, Giaume C. Activity-dependent neuronal control of gap-junctional communication in astrocytes. J Cell Biol. 2000;149: 1513-1526. (Pubitemid 30437623)
58. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science. 1990;247:470-473. (Pubitemid 20044641)
59. Dermietzel R, Traub O, Hwang TK, Beyer E, Bennett MV, Spray DC, Willecke K. Differential expression of three gap junction proteins in developing and mature brain tissues. Proc Natl Acad Sci USA. 1989;86:10148-10152.
60. Yamamoto T, Ochalski A, Hertzberg EL, Nagy JL. On the organization of astrocytic gap junctions in rat brain as suggested by LM and EM immune-histochemistry of connexin43 expression. J Comp Neurol. 1990;302:853-883.
61. Ochalski PAY, Frankenstein UN, Hertzberg EL, Nagy JI. Connexin-43 in rat spinal cord: Localization in astrocytes and identification of heterotypic astro-oligodendrocytic gap junctions. Neuroscience. 1997;76:931-945.
62. Kunzelmann P, Schroder W, Traub O, Steinhauser C, Dermietzel R, Willecke K. Late onset and increasing expression of the gap junction protein connexin30 in adult murine brain and long-term cultured astrocytes. Glia. 1999;25:111-119.
63. Nagy JI, Patel D, Ochalski PAY, Stelmack GL. Connexin30 in rodent, cat and human brain: Selective expression in gray matter astrocytes, colocalization with connexin43 at gap junctions and late developmental appearance. Neuroscience 1999;88:447-468.
64. Gemel J, Valiunas V, Brink PR, Beyer EC. Connexin43 and connexin26 form gap junctions, but not heteromeric channels in co-expressing cells. J Cell Sci 2004;117:2469-2480.
65. Filippov MA, Hormuzdi SG, Fuchs EC, Monyer H. A reporter allele for investigating connexin 26 gene expression in the mouse brain. Eur J Neurosci. 2003;18:3183-3192.
66. Wallraff A, Kohling R, Heinemann U, Theis M, Willecke K, Steinhauser C. The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J Neurosci. 2006;26:5438-5447. (Pubitemid 44318396)
67. Goldberg GS, Moreno AP, Lampe PD. Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP. J Biol Chem. 2002;277:36725-36730.
68. Bedner P, Niessen H, Odermatt B, Kretz M, Willecke K, Harz H. Selective permeability of different connexin channels to the second messenger cyclic AMP. J Biol Chem. 2006;281:6673-6681. (Pubitemid 43847602)
69. Niessen H, Harz H, Bedner P, Kramer K, Willecke K. Selective permeability of different connexin channels to the second messenger inositol 1,4,5- trisphosphate. J Cell Sci. 2000;113:1365-1372. (Pubitemid 30240555)
70. Harris AL. Connexin channel permeability to cytoplasmic molecules. Prog Biophys Mol Bio. 2007;94:120-143.
71. Birouk N, Le Guern E, Maisonobe T, Rouger H, Gouider R, Tardieu S, Gugenheim M, Routon MC, Léger JM, Agid Y, Brice A, Bouche P. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations-clinical and electrophysiological study. Neurology. 1998;50:1074-1082. (Pubitemid 28212840)
72. Hahn AF, Brown WF, Koopman WJ, Feasby TE. X-Hnked dominant hereditary motor and sensory neuropathy. Brain. 1990;113:1511-1525. (Pubitemid 20385928)
73. Hahn AF, Ainsworth PJ, Naus CCG, Mao J, Bolton CF. Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve. 2000:S39-S48.
74. Nicholson G, Nash J. Intermediate nerve conduction velocities define X-linked Charcot-Marie-Tooth neuropathy families. Neurology. 1993;43:2558-64. (Pubitemid 24004545)
75. Rouger H, Le Guern E, Birouk N, Gouider R, Tardieu S, Plassart E, Gugenheim M, Vallat JM, Louboutin JP, Bouche P, Agid Y, Brice A. Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: Characterization of 14 Cx32 mutations in 35 families. Hum Mutat. 1997;10:443-450.
76. Senderek J, Hermanns B, Bergmann C, Boroojerdi B, Bajbouj M, Hungs M, Ramaekers VT, Quasthoff S, Karch D, Schröder JM. X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different con-exin32 mutations. J Neurol Sci. 1999;167:90-101.
77. Hahn AF, Bolton CF, White CM, Brown WF, Tuuha SE, Tan CC, Ainsworth PJ. Genotype/ phenotype correlations in X-linked Charcot-Marie- Tooth disease. Ann NY Acad Sci. 1999;883:366-82.
78. Gutierrez A, England JD, Sumner AJ, Ferer S, Warner LE, Lupski JR, Garcia CA. Unusual electrophysiological findings in X-linked dominant Charcot-Marie-Tooth disease. Muscle Nerve. 2000; 23:182-188.
79. Tabaraud F, Lagrange E, Sindou P, Vandenberghe A, Levy N, Vallat JM. Demyelinating X-linked Charcot-Marie-Tooth disease: Unusual electrophysiological findings. Muscle Nerve. 1999;22: 1442-1447.
80. Rozear MP, Pericak-Vance MA, Fischbeck K, Stajich JM, Gaskell PC Jr, Krendel DA, Graham DG, Dawson DV, Roses AD. Hereditary motor and sensory neuropathy, X-linked: a half century follow-up. Neurology. 1987;37:1460-465.
81. Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakashima K, Kira J, Kaji R, Oka N, Sobue G; Study Group for Hereditary Neuropathy in Japan. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain. 2003;126:134-151.
82. Kuntzer T, Dunand M, Schorderet DF, Vallat JM, Hahn AF, Bogousslavsky J. Phenotypic expression of a Pro 87 to Leu mutation in the connexin 32 gene in a large Swiss family with Charcot-Marie-Tooth neuropathy. J Neurol Sci. 2003;207:77-86.
83. Vondracek P, Seeman P, Hermanova M, Fajkusova L. X-linked Charcot-Marie-Tooth disease: phenotypic expression of a novel mutation Ile127Ser in the GJB1 (connexin 32) gene. Muscle Nerve. 2005; 31:252-255.
84. Sander S, Nicholson GA, Ouvrier RA, McLeod JG, Pollard JD. Charcot-Marie-Tooth disease: histopathological features of the peripheral myelin protein (PMP22) duplication (CMT1A) and connexin32 mutations (CMTX1). Muscle Nerve. 1998;21:217-225.
85. Vital A, Ferrer X, Lagueny A, Vandenberghe A, Latour P, Goizet C, Canron MH, Louiset P, Petry KG, Vital C. Histopathological features of X-linked Charcot-Marie-Tooth disease in 8 patients from 6 families with different connexin32 mutations. J Peripher Nerv Syst 2001;6:79-84.
86. Senderek J, Bergmann C, Quasthoff S, Ramaekers VT, Schroder JM. X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln). Acta Neuropathol. 1998;95:443-449.
87. Kleopa KA, Zamba-Papanicolaou E, Alevra X, Nicolaou P, Georgiou DM, Hadjisavvas A, Kyriakides T, Christodoulou K. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X. Neurology. 2006;66: 96-402.
88. Hahn AF, Ainsworth PJ, Bolton CF, Bilbao JM, Vallat J-M. Pathological findings in the X-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol 2001;101:129-139.
89. Nicholson GA, Yeung L, Corbett A. Efficient neurophysiological selection of X-linked Charcot-Marie-Tooth families. Neurology. 1998;51:1412-16.
90. Nicholson G, Corbett A. Slowing of central conduction in X-linked Charcot-Marie-Tooth neuropathy shown by brain auditory evoked responses. J Neurol Neurosurg Psychiatry. 1996;61:43-46. (Pubitemid 26232026)
91. Bähr M, Andres F, Timmerman V, Nelis E, Van Broeckhoven C, Dichgans J. Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin32 gene. J Neurol Neurosurg Psychiat. 1999;66:202-206. (Pubitemid 29103522)
92. Paulson HL, Garbern JY, Hoban TF, Krajewski KM, Lewis RA, Fischbeck KH, Grossman RI, Lenkinski R, Kamholz JA, Shy ME. Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann Neurol 2002;52:429-434.
93. Kleopa KA, Yum SW, Scherer SS. Cellular mechanisms of connexin32 mutations associated with CNS manifestations. J Neurosci Res 2002;68: 522-534.
94. Taylor RA, Simon EM, Marks HG, Scherer SS. The CNS phenotype of X-linked Charcot-Marie-Tooth disease: more than a peripheral problem. Neurology 2003;61:1475-1478.
95. Marques W, Sweeney MG, Wood NW, Wroe SJ. Central nervous system involvement in a novel connexin 32 mutation affecting identical twins. J Neurol Neurosurg Psychiat. 1999;66:803-804.
96. Panas M, Karadimas C, Avramopoulos D, Vassilopoulos D. Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations. J Neurol Neurosurg Psychiat. 1998;65:947-948.
97. Bell C, Willison H, Clark C, Haites N. CNS abnormalities in a family with a connexin32 mutation and peripheral neuropathy. Eur J Hum Genet. 1996;4:S136.
98. Isoardo G, Di Vito N, Nobile M, Benetton G, Fassio F. X-linked Charcot-Marie-Tooth disease and progressive-relapsing central demyelinating disease. Neurology. 2005;65:1672-1673.
99. Bort S, Nelis E, Timmerman V, Sevilla T, Cruz-Martínez A, Martínez F, Millán JM, Arpa J, Vílchez JJ, Prieto F, Van Broeckhoven C, Palau F. Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet. 1997;99: 746-754.
100. Lee MJ, Nelson I, Houlden H, Sweeney MG, Hilton-Jones D, Blake J, Wood NW, Reilly MM. Six novel connexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth disease. J Neurol Neurosurg Psychiatry 2002;73:304-6.
101. Kawakami H, Inoue K, Sakakihara I, Nakamura S. Novel mutation in X-linked Charcot-Marie-Tooth disease associated with CNS impairment. Neurology 2002;59:923-926.
102. Panas M, Kalfakis N, Karadimas C, Vassilopoulos D. Episodes of generalized weakness in two sibs with the C164T mutation of the connexin 32 gene. Neurology. 2001;57:1906-1908.
103. Schelhaas HJ, Van Engelen BG, Gabreels-Festen AA,Hageman G, Vliegen JH, Van Der Knaap MS, Zwarts MJ. Transient cerebral white matter lesions in a patient with connexin 32 missense mutation. Neurology. 2002;59:2007-2008.
104. Hanemann CO, Bergmann C, Senderek J, Zerres K, Sperfeld A. Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation. Arch Neurol. 2003;60:605-609.
105. Srinivasan J, Leventer RJ, Kornberg AJ, Dahl HH, Ryan MM. Central nervous system signs in X-linked Charcot-Marie-Tooth disease after hyperventilation. Pediatr Neurol. 2008;38:293-295. (Pubitemid 351382131)
106. Halbrich M, Barnes J, Bunge M, Joshi C. A V139M mutation also causes the reversible CNS phenotype in CMTX. Can J Neurol Sci. 2008;35:372-374.
107. Lin GS, Glass JD, Shumas S, Scherer SS, Fischbeck KH. A unique mutation in connexin32 associated with severe, early onset CMTX in a heterozygous female. Ann NY Acad Sci. 1999;883:481-485.
108. Liang GSL, de Miguel M, Gomez-Hernandez JM, Glass JD, Scherer SS, Mintz M, Barrio LC, Fischbeck KH. Severe neuropathy with leaky connexin32 hemichannels. Ann Neurol. 2005;57: 749-754.
109. Karadima G, Panas M, Floroskufi P, Kalfakis N, Vassilopoulos D. A V38A mutation in X-linked Charcot-Marie-Tooth neuropathy with unusual clinical features. J Neurol. 2004;251:222-223.
110. Opjordsmoen S, Nyberg-Hansen R. Hereditary spastic paraplegia with neurogenic bladder disturbances and syndactylia. Acta Neurol Scand. 1980;61:35-41.
111. Norton KK, Carey JC, Gutmann DH. Oculodento-digital dysplasia with cerebral white matter abnormalities in a two-generation family. Am J Med Genet. 1995;57:458-461.
112. Paznekas WA, Boyadjiev SA, Shapiro R, Daniels O, Wollnik B, Keegan CE, Innis JW, Dinulos MB, Christian C, Hannibal MC, Jabs EW. Connexin 43 (GJA1) mutations cause the pleio-tropic phenotype of oculodentodigital dysplasia. Am J Hum Genet. 2003;72:408-418.
113. Shapiro RE, Griffin JW, Stine OC. Evidence for genetic anticipation in the oculodentodigital syndrome. Am J Med Genet 1997;71:36-41.
114. Stanislaw CL, Narvaez C, Rogers RC, Woodard CS. Oculodentodigital dysplasia with cerebral white matter abnormalities: an additional case. Proc Greenwood Genet Center 1998;17:20-24.
115. Wiest T, Herrmann O, Stogbauer F, Grasshoff U, Enders H, Koch MJ, Grond-Ginsbach C, Schwaninger M. Clinical and genetic variability of oculodentodigital dysplasia. Clin Genet 2006;70:71-72.
116. Uhlenberg B, Schuelke M, Ruschendorf F, Ruf N, Kaindl AM, Henneke M, Thiele H, Stoltenburg-Didinger G, Aksu F, Topaloǧlu H, Nürnberg P, Hübner C, Weschke B, Gärtner J. Mutations in the gene encoding gap junction protein alpha 12 (Connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet. 2004;75:251-260.
117. Bugiani M, Al Shahwan S, Lamantea E, Bizzi A, Bakhsh E, Moroni I, Balestrini MR, Uziel G, Zeviani M. GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology. 2006;67:273-279.
118. Salviati L, Trevisson E, Baldoin MC, Toldo I, Sartori S, Calderone M, Tenconi R, Laverda A. A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease. Neurogenetics 2007;8:57-60.
119. Wolf NI, Cundall M, Rutland P, Rosser E, Surtees R, Benton S, Chong WK, Malcolm S, Ebinger F, Bitner-Glindzicz M, Woodward KJ.Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. Neurogenetics. 2007;8:39-44.
120. Henneke M, Combes P, Diekmann S, Bertini E, Brockmann K, Burlina AP, Kaiser J, Ohlenbusch A, Plecko B, Rodriguez D, Boespflug-Tanguy O, Gärtner J. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. Neurology 2008; 70:748-754.
121. Orthmann-Murphy JL, Salsano E, Abrams CK, Bizzi A, Uziel G, Freidin MM, Lamantea E, Zeviani M, Scherer SS, Pareyson D. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain 2009;132:426-438.
122. Nave K-A, Boespflug-Tanguy O. Developmental defects of myelin formation: from X-linked mutations to human dysmyelinating diseases. Neuroscientist 1996;2:33-43.
123. Hudson LD, Garbern JY, Kamholz JA. Pelizaeus-Merzbacher disease. In: RA L, ed. Myelin biology and disorders. Vol. 2. San Diego: Elsevier; 2004; 867-885.
124. Inoue K. PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics. 2005;6:1-16.
125. Garbern J, Cambi F, Shy M, Kamholz J. The molecular pathogenesis of Pelizaeus-Merzbacher disease. Arch Neurol. 1999;56:1210-1214.
126. Garbern JY. Pelizaeus-Merzbacher disease: genetic and cellular pathogenesis. Cell Mol Life Sci 2007;64:50-65.
127. Cailloux F, Gauthier-Barichard F, Mimault C, Isabelle V, Courtois V, Giraud G, Dastugue B, Boespflug-Tanguy O. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Eur J Hum Genet. 2000;8:837-845.
128. Bjartmar c, Kidd G, Mork S, Rudick R, Trapp BD. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl asparate in chronic multiple sclerosis patients. Ann Neurol. 2000;48:893-901.
129. Gorlin RJ, Miskin LH, St Gerne JW. Oculodentodigital dysplasia. J Pediatr. 1963;63:69-75.
130. Gutmann DH, Zackai EH, McDonald-McGinn DM, Fischbeck KH, Kamholz J. Oculodentodigital dysplasia syndrome associated with abnormal cerebral white matter. Am J Med Genet. 1991;41: 18-20.
131. Loddenkemper T, Grote K, Evers S, Oelerich M, Stogbauer F. Neurological manifestations of the oculodentodigital dysplasia syndrome. J Neurol. 2002; 249:584-595. (Pubitemid 34507833)
132. Paznekas WA, Karczeski B, Vermeer S, Lowry RB, Delatycki M, Laurence F, Koivisto PA, Van Maldergem L, Boyadjiev SA, Bodurtha JN, Jabs EW. GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat. 2009;30:724.
133. Abrams CK, Oh S, Ri Y, Bargiello TA. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res Rev. 2000;32:203-214. (Pubitemid 30177326)
134. Bruzzone R, White TW, Scherer S, S, Fischbeck KH, Paul DL. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease. Neuron. 1994;13:1253-1260.
135. Oh S, Ri Y, Bennett MVL, Trexler EB, Verselis VK, Bargiello TA. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron. 1997;19:927-38.
136. Abrams CK, Freidin MM, Verselis VK, Bennett MV, Bargiello TA. Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease. Brain Res. 2001; 900:9-25.
137. Castro C, Gomez-Hernandez JM, Silander K, Barrio LC. Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J Neurosci 1999;19:3752-60.
138. Rabadan-Diehl C, Dahl G, Werner R. A connexin32 mutation associated with Charcot-Marie-Tooth disease does not affect channel formation in oocytes. FEBS Lett 1994;351:90-94.
139. Omori Y, Mesnil M, Yamasaki H. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects. Mol Biol Cell. 1996;7:907-916.
140. Yoshimura T, Satake M, Ohnishi A, Tsutsumi Y, Fujikura Y. Mutations of connexin32 in Charcot-Marie-Tooth disease type X interfere with cell-to-cell communication but not cell proliferation and myelin-specific gene expression. J Neurosci Res. 1998;51:154-161.
141. Yum SW, Kleopa KA, Shumas S, Scherer SS. Diverse trafficking abnormalities of Connexin32 mutants causing CMTX. Neurobiol Dis. 2002;11: 43-52.
142. Deschênes SM, Bone LJ, Fischbeck KH, Scherer SS. Connexin32 and X-linked Charcot-Marie-Tooth disease. In: Spray D, Dermietzel R, eds. The biology of gap junctions. Georgetown, TX: R.G. Landes; 1996:213-227.
143. Deschênes SM, Walcott JL, Wexler TL, Scherer SS, Fischbeck KH. Altered trafficking of mutant connexin32. J Neurosci. 1997;17:9077-9084.
144. Martin PEM, Mambetisaeva ET, Archer DA, George CH, Evans WH. Analysis of gap junctions assembly using mutated connexins detected in Charcot-Marie-Tooth X-linked disease. J Neurochem 2000;74:711-720.
145. Matsuyama W, Nakagawa M, Moritoyo T, Takashima H, Umehara F, Hirata K, Suehara M, Osame M. Phenotypes of X-linked Charcot-Marie-Tooth disease and altered trafficking of mutant Connexin 32 (GJB1). J Hum Genet. 2001;46:307-13.
146. VanSlyke JK, Deschênes SM, Musil LS. Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins. Mol Biol Cell. 2000;11:1933-1946.
147. Abrams CK, Bennett MVL, Verselis VK, Bargiello TA. Voltage opens unopposed gap junction hemi-channels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease. Proc Natl Acad Sci U S A. 2002;99:3980-4.
148. Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. J Neurosci 2005;25:1550-1559.
149. Sutor B, Schmolke C, Teubner B, Schirmer C, Willecke K. Myelination defects and neuronal hyperexcitability in the neocortex of connexin 32- deficient mice. Cereb Cortex. 2000;10:684-697.
150. Abel A, Bone LJ, Messing A, Scherer SS, Fischbeck KF. Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. J Neuropathol Exp Neurol. 1999;58:702-710. (Pubitemid 29328499)
151. Scherer SS, Bone LJ, Deschênes SM, Abel A, Balice-Gordon R, Fischbeck K. The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease. In: Cardew G, ed. Gap junction-mediated intercellular signalling in health and disease. Vol. Novartis Foundation Symposium 219. New York: John Wiley & Sons; 1999:175-185.
152. Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, Ainsworth PJ, Lewis RA, Scherer SS, Hahn AF.CMT1X phenotypes represent loss of GJB1 gene function. Neurology. 2007;68:849-855. (Pubitemid 46568537)
153. Nakagawa M, Takashima H, Umehara F, Arimura K, Miyashita F, Takenouchi N, Matsuyama W, Osame M. Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci. 2001;185:31-36.
154. Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS. Loss-of-function connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci. 2007;34:629-641.
155. Rash JE, Duffy HS, Dudek FE, Bilhartz BL, Whalen LR, Yasumura T. Grid-mapped freeze-fracture analysis of gap junctions in gray and white matter of adult rat central nervous system, with evidence for a "panglial syncytium" that is not coupled to neurons. J Comp Neurol. 1997;388:265-92.
156. Hansson E, Muyderman H, Leonova J, Allansson L, Sinclair J, Blomstrand F, Thorlin T, Nilsson M, Rönnbäck L. Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication. Neurochem Int 2000;37:317-329.
157. Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience. 2004;129: 1043-1054.
158. Menichella DM, Majdan M, Awatramani R, Goodenough DA, Sirkowski E, Scherer SS, Paul DL.Genetic and physiological evidence that oligodendrocyte gap junctions contribute to spatial buffering of potassium released during neuronal activity. J Neurosci. 2006;26:10984-10991.
159. De Pina-Benabou MH, Srinivas M, Spray DC, Scemes E. Calmodulin kinase pathway mediates the K+-induced increase in Gap junctional communication between mouse spinal cord astrocytes. J Neurosci. 2001;21:6635-6643.
160. Amzica F, Massimini M, Manfridi A. Spatial buffering during slow and paroxysmal sleep oscillations in cortical networks of glial cells in vivo. J Neurosci. 2002;22:1042-1053. (Pubitemid 34141784)
161. Seki A, Coombs W, Taffet SM, Delmar M. Loss of electrical communication, but not plaque formation, after mutations in the cytoplasmic loop of connexin43. Heart Rhythm. 2004;1:227-233.
162. Roscoe W, Veitch GI, Gong XQ, Pellegrino E, Bai D, McLachlan E, Shao Q, Kidder GM, Laird DW. Oculo-dentodigital dysplasia-causing connexin43 mutants are non-functional and exhibit dominant effects on wild-type connexin43. J Biol Chem. 2005;280:11458-11466.
163. Shibayama J, Paznekas W, Seki A, Taffet S, Jabs EW, Delmar M, Musa H. Functional characterization of connexin43 mutations found in patients with oculodentodigital dysplasia. Circ Res. 2005; 96:e83-e91.
164. McLachlan E, Manias JL, Gong XQ, Lounsbury CS, Shao Q, Bernier SM, Bai D, Laird DW. Functional characterization of oculodentodigital dysplasiaassociated Cx43 mutants. Cell Commun Adhes. 2005;12:279-292.
165. Lai A, Le DN, Paznekas WA, Gifford WD, Jabs EW, Charles AC. Oculodentodigital dysplasia connexin43 mutations result in non-functional connexin hemichannels and gap junctions in C6 glioma cells. J Cell Sci. 2006;119:532-541.
166. Beahm DL, Oshima A, Gaietta GM, Hand GM, Smock AE, Zucker SN, Toloue MM, Chandrasekhar A, Nicholson BJ, Sosinsky GE. Mutation of a conserved threonine in the third transmembrane helix of alpha- and beta-connexins creates a dominant-negative closed gap junction channel. J Biol Chem. 2006;281:7994-8009.
167. Gong XQ, Shao Q, Lounsbury CS, Bai D, Laird DW. Functional characterization of a GJA1 frameshift mutation causing oculodentodigital dysplasia and palmoplantar keratoderma. J Biol Chem 2006;281:31801-31811.
168. Gong XQ, Shao Q, Langlois S, Bai D, Laird DW. Differential potency of dominant negative connexin43 mutants in oculodentodigital dysplasia. J Biol Chem. 2007;282:19190-19202.
169. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science. 1995;267:1831-1834.
170. Theis M, Jauch R, Zhuo L, Speidel D, Wallraff A, Döring B, Frisch C, Söhl G, Teubner B, Euwens C, Huston J, Steinhäuser C, Messing A, Heinemann U, Willecke K.Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. J Neurosci 2003;23: 766-776.
171. Flenniken AM, Osborne LR, Anderson N, Ciliberti N, Fleming C, Gittens JE, Gong XQ, Kelsey LB, Lounsbury C, Moreno L, Nieman BJ, Peterson K, Qu D, Roscoe W, Shao Q, Tong D, Veitch GI, Voronina I, Vukobradovic I, Wood GA, Zhu Y, Zirngibl RA, Aubin JE, Bai D, Bruneau BG, Grynpas M, Henderson JE, Henkelman RM, McKerlie C, Sled JG, Stanford WL, Laird DW, Kidder GM, Adamson SL, Rossant J. A Gja1 missense mutation in a mouse model of oculo-dentodigital dysplasia. Development. 2005;132: 4375-4386.
172. Houghton FD, Thonnissen E, Kidder GM, Naus CCG, Willecke K, Winterhager E. Doubly mutant mice, deficient in connexin32 and -43, show normal prenatal development of organs where the two gap junction proteins are expressed in the same cells. Devel Genetics. 1999;24:5-12.
173. Yu Q, Shen Y, Chatterjee B Leatherbury L, Rosenthal J, Lucas JF, Wessels A, Spurney CF, Wu YJ, Kirby ML, Svenson K, Lo CW. ENU induced mutations causing congenital cardio-vascular anomalies. Development. 2004;131:6211-23.
174. Lutz SE, Zhao Y, Gulinello M, Lee SC, Raine CS, Brosnan CF. Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci 2009;9: 7743-52.